The pandemic of coronavirus disease 2019 (COVID‐19), caused by the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused an unprecedented global …

Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …

The number of COVID-19 patients is dramatically increasing worldwide. Treatment in
intensive care units (ICU) has become a major challenge; therefore, early recognition of …

Objectives Studies reported associations of inflammatory markers with the severity of COVID-
19, but conclusions were inconsistent. We aimed to provide an overview of the association …

Background The aim of this study is to evaluate the impact of diabetes, hypertension,
cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin …

Abstract Coronavirus Disease 2019 (COVID-19) has quickly progressed to a global health
emergency. Respiratory illness is the major cause of morbidity and mortality in these …

Coronavirus disease 2019 is a pandemic influencing the first half of the year 2020. The virus
has rapidly spread to many countries. Studies are rapidly published to share information …

Introduction: As the coronavirus disease 2019 (COVID-19) outbreak, identification of clinical
predictors of severe or fatal disease are necessary to enable risk stratification and optimize …

The recent outbreak of COVID-19 has been rapidly spreading on a global scale. To date,
there is no specific vaccine against the causative virus, SARS-CoV-2, nor is there an …

Objective To explore the clinical value of immune-inflammatory markers to assess the
severity of coronavirus disease 2019 (COVID-19). Methods 127 consecutive hospitalized …